JP2014201588A - Medicine-impregnated sheet with controlled zeta potential and face mask - Google Patents

Medicine-impregnated sheet with controlled zeta potential and face mask Download PDF

Info

Publication number
JP2014201588A
JP2014201588A JP2013082174A JP2013082174A JP2014201588A JP 2014201588 A JP2014201588 A JP 2014201588A JP 2013082174 A JP2013082174 A JP 2013082174A JP 2013082174 A JP2013082174 A JP 2013082174A JP 2014201588 A JP2014201588 A JP 2014201588A
Authority
JP
Japan
Prior art keywords
impregnated sheet
zeta potential
chemical
skin
sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013082174A
Other languages
Japanese (ja)
Inventor
暁 吉田
Akira Yoshida
暁 吉田
博文 小野
Hirobumi Ono
博文 小野
池永 秀雄
Hideo Ikenaga
秀雄 池永
寿美 中村
Sumi Nakamura
寿美 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Fibers Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Fibers Corp filed Critical Asahi Kasei Fibers Corp
Priority to JP2013082174A priority Critical patent/JP2014201588A/en
Publication of JP2014201588A publication Critical patent/JP2014201588A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a medicine-impregnated sheet of high adhesion, and a face mask prepared using the same.SOLUTION: This invention relates to a medicine-impregnated sheet in which an absolute value of a surface zeta potential on at least one face is in the range of 35 mV or more and 250 mV or less, and a face mask prepared using the same.

Description

本発明はゼータ電位が制御された薬液含浸シート及びそれを用いたフェイスマスクに関する。詳しくはゼータ電位が適性値に制御されていることにより、人体への装着時の皮膚密着性が格別に高く、薬液の保液性に優れていることを特徴とする、薬液含浸シート及びそれを用いたフェイスマスクに関するものである。   The present invention relates to a chemical liquid impregnated sheet having a controlled zeta potential and a face mask using the same. Specifically, the zeta potential is controlled to an appropriate value, so that the skin adhesion at the time of wearing on the human body is exceptionally high and the liquid retention property of the chemical is excellent, It relates to the used face mask.

近年、薬液を含浸したシートおよびフェイスマスクが、健康や美容意識の高まりとともに、特に多忙な現代女性のアンチエイジング商品として拡大している。これらのシートおよびフェイスマスクに使用する素材は、キュプラ長繊維やコットン、レーヨンに代表されるセルロース系の繊維であり、その不織布がその代表例である。セルロース系繊維不織布が好適に用いられる理由としては、合成繊維系不織布に比べ親水性が大きい為、薬液の保液性能が高く装着時の液持ちが良く、装着時の湿潤状態を維持できる時間が長く、薬液を肌に浸透させやすいことが挙げられる。   In recent years, sheets and face masks impregnated with medicinal solutions are expanding as anti-aging products for particularly busy modern women as health and beauty awareness increase. The materials used for these sheets and face masks are cellulosic fibers represented by cupra long fibers, cotton and rayon, and their nonwoven fabrics are typical examples. The reason why cellulose-based non-woven fabrics are preferably used is that they have a higher hydrophilicity than synthetic non-woven fabrics, so the liquid retention of chemicals is high, the liquids are good when worn, and the time during which they can be kept wet when worn For example, it is long and easy to penetrate the skin into the skin.

セルロース系繊維不織布の中でもキュプラ長繊維不織布(旭化成せんい(株)製 ベンリーゼTM)は、セルロース系繊維の中では結晶化度が小さいため、薬液の保液性が高く、湿潤時の柔軟性が高く、装着時の追従性や密着感(肌への張り付き性)に優れている。又連続長繊維からなる不織布であり、断面形状が丸断面であるため、装着時に肌あたりの優しい素材として特に好適な素材として用いられている。
しかし、フェイスマスクや美容用シートの薬液含浸シートとして近年、装着時の顔の曲面や凹凸に追随して密着性を発現するシートが求められている。特に着用初期から取り外すまでの間の移動や会話や表情の変化に対しても、剥がれることのない高い密着性が求められる様になってきた。
Cupra filament nonwoven Among cellulosic fiber nonwoven fabric (Asahi Kasei Fibers Corp. Bemliese TM), because the degree of crystallinity in cellulose fibers is small, high liquid retention chemical solution, high flexibility when wet , It is excellent in following ability and adhesion (wearing to the skin) at the time of wearing. Moreover, since it is a nonwoven fabric consisting of continuous long fibers and the cross-sectional shape is a round cross section, it is used as a particularly suitable material as a gentle material per skin when worn.
However, as a chemical solution impregnated sheet for face masks and cosmetic sheets, in recent years, there has been a demand for a sheet that exhibits adhesiveness following the curved surface and unevenness of the face when worn. In particular, high adhesion without peeling has been demanded even during movements from the initial wear to removal and changes in conversation and facial expressions.

そこで高密着性を得るための美容シートの改良としては、単繊維直径が1〜500nmの熱可塑性樹脂からなるナノファイバーより構成された不織布層を貼付面として使用するフェイスパックが提案されている(下記特許文献1参照)。しかし、特許文献1に記載のナノファイバーは、熱可塑性樹脂から構成されている為、湿潤時の柔軟性に劣り、密着性の観点からは、十分満足できるレベルには至っていないのが実情であった。   Therefore, as an improvement of the beauty sheet for obtaining high adhesion, a face pack using a nonwoven fabric layer composed of nanofibers made of a thermoplastic resin having a single fiber diameter of 1 to 500 nm as a sticking surface has been proposed ( See Patent Document 1 below). However, since the nanofiber described in Patent Document 1 is composed of a thermoplastic resin, it is inferior in flexibility when wet, and in reality, it has not reached a sufficiently satisfactory level from the viewpoint of adhesion. It was.

又、下記特許文献2には、親水性繊維を50質量%以上含む親水性繊維層の一方又は両方の表面に、繊度0.5dtex以下である極細繊維を10質量%以上含む極細繊維層が位置し、極細繊維層を皮膚との接触面とする化粧料含浸用皮膚被覆シート及び液体化粧料が含浸されたフェイスマスクが提案されている。しかし、特許文献2には、親水性繊維としてレーヨンやパルプ等のセルロース系繊維が開示されているが、実施例で具体的に用いられている繊維は、繊度0.5dtex以下の極細繊維として熱可塑性樹脂からなる分割型複合繊維である為、特許文献1と同様に湿潤時の柔軟性に劣り、密着性の観点からは充分満足できるレベルには至っていない。   In Patent Document 2 below, an ultrafine fiber layer containing 10% by mass or more of ultrafine fibers having a fineness of 0.5 dtex or less is located on one or both surfaces of the hydrophilic fiber layer containing 50% by mass or more of hydrophilic fibers. In addition, a skin covering sheet for impregnating cosmetics having an ultrafine fiber layer as a contact surface with the skin and a face mask impregnated with liquid cosmetics have been proposed. However, Patent Document 2 discloses cellulosic fibers such as rayon and pulp as hydrophilic fibers, but the fibers specifically used in the examples are heated as ultrafine fibers having a fineness of 0.5 dtex or less. Since it is a split type composite fiber made of a plastic resin, it is inferior in flexibility when wet as in Patent Document 1, and has not reached a sufficiently satisfactory level from the viewpoint of adhesion.

特許第4816312号公報Japanese Patent No. 4816312 特許第3944526号公報Japanese Patent No. 3944526

本発明の目的は、かかる状況に鑑み、装着したときの密着性が従来の不織布では達成できなかった高密着性の薬液含浸シート及びそれを用いたフェイスマスクを提供することにある。更には薬液の保液性能および有効成分の徐放性に優れた薬液含浸シートおよびそれを用いたフェイスマスクを提供することにある。   In view of such circumstances, an object of the present invention is to provide a highly adhesive chemical liquid impregnated sheet that cannot be achieved with a conventional nonwoven fabric when attached and a face mask using the same. Furthermore, it is providing the chemical | medical solution impregnation sheet | seat excellent in the liquid retention performance of a chemical | medical solution, and the sustained release of an active ingredient, and a face mask using the same.

本発明者らは、薬液含浸シート、とりわけ美容シート及びフェイスマスクに求められる密着性、保液性および成分徐放性を具有する性能の発現には、繊維径を細繊化するのみでは不十分であり、皮膚が電位を有し又、電位が皮膚に作用することを活用することが必要と考え、鋭意検討した結果、本発明に至った。
即ち、本発明は下記の発明を提供する。
The inventors of the present invention are not sufficient to make the fiber diameter finer in order to develop the performance having the adhesion, liquid retention, and component sustained release properties required for chemical liquid impregnated sheets, especially beauty sheets and face masks. As a result of intensive studies on the fact that it is necessary to utilize the fact that the skin has a potential and the potential acts on the skin, the present invention has been achieved.
That is, the present invention provides the following inventions.

(1)少なくとも片面の表面ゼータ電位の絶対値が35mV以上250mV以下の範囲にあることを特徴とする薬液含浸シート。
(2)繊維からなる構造体から構成され、少なくとも表面ゼータ電位が前記範囲にある面の平均繊維径が0.01μm以上50μm以下であり、かつ空隙率が50%から90%であることを特徴とする上記1項に記載の薬液含浸シート。
(3)前記構造体がセルロース系繊維の不織布を含むことを特徴とする上記2項に記載の薬液含浸シート。
(4)シート100重量部に対して100〜2000重量部の薬液が含浸されていることを特徴とする上記1〜3項のいずれか一項に記載の薬液含浸シート。
(5)上記1〜4項のいずれか一項に記載の薬液含浸シートからなることを特徴とするフェイスマスク。
(1) A chemical solution-impregnated sheet, wherein the absolute value of at least one surface zeta potential is in the range of 35 mV to 250 mV.
(2) It is composed of a structure composed of fibers, and has an average fiber diameter of at least 0.01 μm and not more than 50 μm and a porosity of 50% to 90% at least in the range where the surface zeta potential is in the above range. The chemical liquid impregnated sheet according to the above item 1.
(3) The chemical solution impregnated sheet as described in (2) above, wherein the structure comprises a cellulose-based non-woven fabric.
(4) The chemical liquid impregnated sheet according to any one of the above items 1 to 3, wherein 100 to 2000 parts by weight of the chemical liquid is impregnated with respect to 100 parts by weight of the sheet.
(5) A face mask comprising the chemical liquid impregnated sheet according to any one of items 1 to 4 above.

本発明は、ゼータ電位が適性値に制御された薬液含浸シート及びそれを用いたフェイスマスクであり、従来品に比べ装着時の密着性が格別に高く、且つ薬液の保液性と皮膚への薬液浸透が優れた製品設計を可能にする。   The present invention is a chemical solution impregnated sheet in which the zeta potential is controlled to an appropriate value and a face mask using the same, and the adhesion at the time of wearing is remarkably higher than that of a conventional product, and the liquid retention property of the chemical solution and the skin Enables product design with excellent chemical penetration.

以下、本発明を詳細に説明する。
本発明は、表面ゼータ電位の絶対値が35mV以上250mV以下の範囲にあることを特徴とする薬液含浸シートである。より好ましくは40mV以上200mV以下の範囲である。この範囲に制御すると、皮膚と接触させた際の密着性や、皮膚への薬液の浸透性をコントロールすることが可能となる。
例えば、健康な皮膚の表面は−40mV程度のゼータ電位を示すとされる。これに対し、カチオン性の置換基をもった化合物、例えば4級アンモニウム基等を保有する化合物を、物理吸着や表面反応により本発明のシート表面に導入すると、皮膚と本発明の表面とが静電的な相互作用を介して、密着性が増大するため好ましいものとなる。
Hereinafter, the present invention will be described in detail.
The present invention is the chemical solution impregnated sheet, wherein the absolute value of the surface zeta potential is in the range of 35 mV to 250 mV. More preferably, it is the range of 40 mV or more and 200 mV or less. By controlling within this range, it is possible to control the adhesion when brought into contact with the skin and the permeability of the drug solution into the skin.
For example, a healthy skin surface is said to exhibit a zeta potential of about −40 mV. In contrast, when a compound having a cationic substituent, for example, a compound having a quaternary ammonium group or the like is introduced to the surface of the sheet of the present invention by physical adsorption or surface reaction, the skin and the surface of the present invention are statically separated. This is preferable because adhesion is increased through electrical interaction.

一方、表面反応により、強いアニオン性の置換基をもった化合物、例えばスルホン基を有するp−ベンゼンスルホン酸基やアルキルスルホン酸基を保有する化合物を適量導入するとマイナスの大きな表面ゼータ電位に制御することができる。皮膚に接触する表面と皮膚の間に大きな表面電位差を設けると皮膚の表面に電場を印荷したのと同様の効果が発現する。特開2002−291909号公報によると皮膚の表面に500mV程度の負の直流電場を与えると皮膚のバリアー機能回復に顕著な効果が発現するとされる。本発明の薬液含浸シートの皮膚接触面に例えば絶対値として100mV程度のゼータ電位を付与すると同様の効果を発現させることができる。   On the other hand, when a suitable amount of a compound having a strong anionic substituent, for example, a p-benzenesulfonic acid group having a sulfone group or an alkylsulfonic acid group, is introduced by a surface reaction, the surface zeta potential is controlled to a large negative value. be able to. When a large surface potential difference is provided between the surface in contact with the skin and the skin, the same effect as that when an electric field is applied to the surface of the skin appears. According to Japanese Patent Laid-Open No. 2002-291909, it is said that when a negative DC electric field of about 500 mV is applied to the surface of the skin, a remarkable effect appears in the recovery of the skin barrier function. When a zeta potential of about 100 mV, for example, as an absolute value is applied to the skin contact surface of the chemical liquid impregnated sheet of the present invention, the same effect can be exhibited.

さらに、薬液含浸シートに含浸されている薬液中に、電荷を保有するイオン性の化合物が含まれている場合には、シートと皮膚との間に電位差(電場)を設けることにより、該化合物そのもの、あるいは該化合物と相互作用する化合物を併せて皮膚へ送り込む、すなわち電場勾配によるポンプ作用を付与することができ、皮膚への薬液浸透性を高めることができ、有効である場合もある。すなわち、ゼータ電位を所定の範囲に制御することにより、本発明で規定される皮膚への密着性の高いシートの機能に加え、含浸している薬液の皮膚への浸透促進など、従来品に見られなかった複数の効果を付与することが可能となる。該効果は薬液含浸シートに求められるニーズに合わせて適宜選定し、求められる効果に適したゼータ電位を設定すればよく、上記に記載の化合物、置換基に特に限定されるものではない。   Further, when the chemical liquid impregnated in the chemical liquid-impregnated sheet contains an ionic compound having a charge, the compound itself is provided by providing a potential difference (electric field) between the sheet and the skin. Alternatively, a compound that interacts with the compound can be delivered to the skin, that is, a pumping action by an electric field gradient can be imparted, and the medicinal solution permeability to the skin can be increased, which is sometimes effective. In other words, by controlling the zeta potential within a predetermined range, in addition to the function of the sheet having high adhesion to the skin defined in the present invention, the conventional product has been observed such as promoting the penetration of the impregnating chemical into the skin. It becomes possible to provide a plurality of effects that were not achieved. The effect may be appropriately selected according to the needs required for the chemical-impregnated sheet, and a zeta potential suitable for the required effect may be set, and is not particularly limited to the compounds and substituents described above.

なお、本発明の薬液含浸シートにおいて、上記表面ゼータ電位を有する面は両面である必要性はなく、少なくとも片面であればよい。片面の場合は、人体に装着した場合に、上記表面ゼータ電位を有する面を皮膚に接触する側になるように製品設計すればよい。   In the chemical liquid impregnated sheet of the present invention, the surface having the surface zeta potential does not have to be both surfaces, and may be at least one surface. In the case of one side, the product may be designed so that the surface having the surface zeta potential is the side in contact with the skin when worn on the human body.

本発明の薬液含浸シートは、繊維からなる構造体であることが好ましく、皮膚に接触する面の平均繊維径が0.01μm以上50μm以下であることが好ましい。より好ましくは0.02μm以上30μm以下である。50μm以上となると、表面積が小さいものとなりゼータ電位を付与することが困難となり、もはや密着性を向上させることが出来なくなる。一方、0.01μm以下は極めて微細であるため生産が困難であり、経済性から好ましいとは言い難く、現実的ではない。   The chemical liquid impregnated sheet of the present invention is preferably a structure composed of fibers, and the average fiber diameter of the surface in contact with the skin is preferably 0.01 μm or more and 50 μm or less. More preferably, it is 0.02 μm or more and 30 μm or less. When the thickness is 50 μm or more, the surface area becomes small and it becomes difficult to apply a zeta potential, and the adhesion cannot be improved anymore. On the other hand, since 0.01 micrometer or less is very fine, production is difficult, and it is hard to say that it is preferable from economical viewpoint, and is not realistic.

また本発明の薬液含浸シートの空隙率は50%から90%である必要があることが好ましく、より好ましくは60%から85%である。50%を下回ると薬液や化粧液の保液性が悪く、またシートが剛直なものとなるため、皮膚に接触した際、追従性が損なわれる為、好ましくない。一方、90%を上回ると薬液は大量に含浸できるが、柔らかすぎる為、ハンドリングに難が生じてしまう。   Moreover, it is preferable that the porosity of the chemical | medical solution impregnation sheet | seat of this invention needs to be 50 to 90%, More preferably, it is 60 to 85%. If it is less than 50%, the liquid or cosmetic liquid retainability is poor, and the sheet becomes rigid, so that the followability is impaired when it comes into contact with the skin. On the other hand, if it exceeds 90%, a large amount of chemical solution can be impregnated, but since it is too soft, handling becomes difficult.

本発明において、繊維からなる構造体はセルロース系繊維を含む不織布であることが、薬液保持性、徐放性の観点から見て適している。セルロース系繊維の割合は、好ましくは30wt%から100wt%であり、より好ましくは50wt%から100wt%である。30wt%を下回ると薬液の保持性が不十分となり、所望の薬液を一定時間皮膚上に保持することが困難となる。   In the present invention, the structure composed of fibers is suitably a nonwoven fabric containing cellulosic fibers, from the viewpoints of drug solution retention and sustained release. The proportion of cellulosic fibers is preferably 30 wt% to 100 wt%, more preferably 50 wt% to 100 wt%. If it is less than 30 wt%, the retention of the chemical solution becomes insufficient, and it becomes difficult to hold the desired chemical solution on the skin for a certain period of time.

本発明のセルロース系繊維の素材は、セルロースからなる針葉樹パルプ、広葉樹パルプ、コットン由来パルプ、麻由来パルプ、ケナフ由来パルプ、竹由来パルプ、バガス由来パルプ、バクテリアセルロース、レーヨン、キュプラ、リヨセル等の純粋なセルロース繊維の他に、セルロースアセテート、セルロースアセテートプロピオネート、セルロースアセテートブチレート、カルボキシルメチルセルロース、カルボキシルエチルセルロース、ニトロセルロース、メチルセルロースのようなセルロース誘導体繊維から選定される。これらの繊維径は、特に限定されるものではなく、又繊維長も何ら限定されるものではなく短繊維(繊維長2mm〜100mm)や長繊維を用いることができるが、このうちキュプラ、リヨセル等の再生セルロースからなる長繊維は結晶化度が小さいため、薬液の保液性が高いことや湿潤時の柔軟性が高く、装着時の追従性に優れるという効果があるため、特に好ましい。   The cellulose-based fiber material of the present invention is pure cellulose pulp, rayon, cupra, lyocell, etc. made of cellulose softwood pulp, hardwood pulp, cotton-derived pulp, hemp-derived pulp, kenaf-derived pulp, bamboo-derived pulp, bagasse-derived pulp, etc. In addition to various cellulose fibers, it is selected from cellulose derivative fibers such as cellulose acetate, cellulose acetate propionate, cellulose acetate butyrate, carboxymethylcellulose, carboxyethylcellulose, nitrocellulose, and methylcellulose. These fiber diameters are not particularly limited, and the fiber length is not limited at all, and short fibers (fiber length 2 mm to 100 mm) and long fibers can be used. Of these, cupra, lyocell, etc. The long fiber made of regenerated cellulose is particularly preferable because it has a low crystallinity and thus has a high liquid-retaining property, high flexibility when wet, and excellent followability when worn.

薬液含浸漬が阻害されることが無い範囲で、他の繊維を混合しても良い。例えば強度を向上させるために、ポリエチレン繊維、ポリプロピレン繊維、ナイロン繊維、ポリケトン繊維、ポリエステル繊維などの繊維を含んだものでも良い。   You may mix another fiber in the range which does not inhibit chemical | medical solution containing immersion. For example, in order to improve the strength, fibers including polyethylene fibers, polypropylene fibers, nylon fibers, polyketone fibers, polyester fibers and the like may be used.

本発明の薬液含浸シートの皮膚面の素材は特に限定されないが、セルロース繊維を含むと電荷をもった置換基を導入しやすく、ゼータ電位を制御するのに都合がよい。電荷をもった置換基の導入方法として、物理吸着と表面反応の2種類の方法を挙げることができる。物理吸着法の場合、セルロース繊維表面が通常−30mV程度のゼータ電位を保有することを利用し、該表面にカチオン性の置換基を有する化合物を物理吸着させ、固定化させる。吸着の原動力には電荷間の相互作用以外に、水素結合による引力的相互作用も働くため、強カチオン性の化合物をうまく吸着させれば本手法により+100mV程度までのプラスの電荷を導入することが可能である。さらにこうしてプラスに荷電している表面上に今度はマイナスの電荷をもつ化合物を同じように物理吸着させることによりマイナスの表面電位を付与させることが可能である。このような交互吸着の技術を駆使することにより、微細セルロース繊維の表面を−150mV以上+150mV以下のゼータ電位の範囲に制御することが可能である。   The material for the skin surface of the chemical-impregnated sheet of the present invention is not particularly limited. However, inclusion of cellulose fibers facilitates the introduction of a charged substituent and is convenient for controlling the zeta potential. As methods for introducing a substituent having a charge, two methods, physical adsorption and surface reaction, can be mentioned. In the case of the physical adsorption method, utilizing the fact that the cellulose fiber surface usually has a zeta potential of about −30 mV, a compound having a cationic substituent is physically adsorbed on the surface and immobilized. In addition to the interaction between charges, the motive force of adsorption also acts as an attractive interaction due to hydrogen bonding. Therefore, if a strong cationic compound is successfully adsorbed, a positive charge of up to about +100 mV can be introduced by this method. Is possible. Further, a negative surface potential can be imparted by physically adsorbing a negatively charged compound in the same manner on the positively charged surface. By making full use of such an alternate adsorption technique, the surface of the fine cellulose fiber can be controlled in a zeta potential range of −150 mV to +150 mV.

このような物理吸着法では微細セルロース繊維の表面にカチオン性またはアニオン性の化合物を吸着固定化させるが、具体的には、アミン塩基や4級アンモニウム塩基、カルボン酸塩基、スルホン酸塩基、リン酸塩基、硝酸塩基などを分子中に有するイオン性の化合物、更に具体的には、アルキル硫酸エステル塩、ポリオキシエチレンアルキル硫酸エステル塩、アルキルベンゼンスルホン酸塩、α−オレフィンスルホン酸塩などのアニオン界面活性剤、塩化アルキルトリメチルアンモニウム、塩化ジアルキルジメチルアンモニウム、塩化ベンザルコニウムなどのカチオン界面活性剤やカチオン化ポリビニルアルコールやアニオン化ポリビニルアルコールに代表されるようなイオン性の水溶性高分子を挙げることができるがこれらに限定されるものではない。   In such a physical adsorption method, a cationic or anionic compound is adsorbed and immobilized on the surface of fine cellulose fibers. Specifically, amine base, quaternary ammonium base, carboxylate base, sulfonate group, phosphoric acid An ionic compound having a base or nitrate group in the molecule, more specifically, anionic surface activity such as alkyl sulfate ester salt, polyoxyethylene alkyl sulfate ester salt, alkylbenzene sulfonate, α-olefin sulfonate And cationic surfactants such as agents, alkyltrimethylammonium chloride, dialkyldimethylammonium chloride, benzalkonium chloride, and ionic water-soluble polymers such as cationized polyvinyl alcohol and anionized polyvinyl alcohol. Is limited to these Not to.

次に、電荷をもった置換基の第二の導入方法としての表面反応法について説明する。本発明の薬液含浸シートに含まれるセルロース繊維には表面に多数の水酸基が含まれるため、該水酸基の反応性を利用して化学反応により電荷をもった化合物を導入する。この際の化学反応としては、水酸基への反応、すなわちエステル化、エーテル化、シリケート化、ウレタン化、TEMPO酸化によるカルボキシル化等に代表されるすべての化学反応を利用することが可能である。本法では、化合物の構造を自由に設計できるため、例えば強イオン性の置換基を反応部位とやや離れた位置に設計した化合物(例として、パラ−ベンゼンスルホン酸塩イソシアネート)と表面反応させることにより、絶対値として大きな表面電位を導入することが可能であり、本発明の薬液含浸シートの皮膚との接触面の表面ゼータ電位が−250mV以上+250mV以下の範囲に制御することが可能となる。こうした表面反応法により、カチオン基として、アミン塩基や4級アンモニウム塩基、アニオン基として、カルボン酸塩基、スルホン酸塩基、リン酸塩基、硝酸塩基を導入することができる。   Next, a surface reaction method as a second method for introducing a charged substituent will be described. Since the cellulose fiber contained in the chemical liquid impregnated sheet of the present invention contains a large number of hydroxyl groups on the surface, a compound having a charge is introduced by a chemical reaction utilizing the reactivity of the hydroxyl groups. As the chemical reaction at this time, it is possible to use all chemical reactions represented by reactions to hydroxyl groups, that is, esterification, etherification, silicateization, urethanization, carboxylation by TEMPO oxidation, and the like. In this method, since the structure of the compound can be designed freely, for example, surface reaction with a compound (for example, para-benzenesulfonate isocyanate) designed with a strong ionic substituent located slightly away from the reaction site. Thus, it is possible to introduce a large surface potential as an absolute value, and the surface zeta potential of the contact surface with the skin of the chemical liquid impregnated sheet of the present invention can be controlled in the range of −250 mV to +250 mV. By such a surface reaction method, an amine base or a quaternary ammonium base can be introduced as a cationic group, and a carboxylate base, a sulfonate group, a phosphate base, or a nitrate base can be introduced as an anion group.

本発明の薬液含浸シートにおいては、目付の総和が10g/m2以上以200g/m2以下のものが好適に用いられる。10g/m2未満であると、機械的強度が得られず肌面に装着するときの取り扱い性が悪くなる。200g/m2を超えると、湿潤時の柔軟性が劣るため高い密着感が得られない。好ましくは、15g/m2以上150g/m2以下で、より好ましくは、20g/m2以上120g/m2以下である。 In the chemical solution impregnated sheet of the present invention, those having a total weight per unit area of 10 g / m 2 or more and 200 g / m 2 or less are preferably used. If it is less than 10 g / m 2 , the mechanical strength cannot be obtained, and the handleability when worn on the skin surface is deteriorated. When it exceeds 200 g / m 2 , the flexibility when wet is inferior, and a high adhesion feeling cannot be obtained. Preferably, at 15 g / m 2 or more 150 g / m 2 or less, more preferably 20 g / m 2 or more 120 g / m 2 or less.

本発明の薬液含浸シートに使用するシートの膜厚は、20μm以上800μm以下であることが好ましい。膜厚が20μm未満であると、機械的強度が小さく取り扱い性の悪いものとなってしまう。800μmを超えると追従性が悪くなり、密着性能を損ねてしまう。好適に使用するために、好ましくは30μm以上600μm以下、より好ましくは50μm以上500μm以下である。   The film thickness of the sheet used for the chemical liquid impregnated sheet of the present invention is preferably 20 μm or more and 800 μm or less. If the film thickness is less than 20 μm, the mechanical strength is small and the handleability is poor. If it exceeds 800 μm, the followability is deteriorated and the adhesion performance is impaired. In order to use suitably, Preferably they are 30 micrometers or more and 600 micrometers or less, More preferably, they are 50 micrometers or more and 500 micrometers or less.

本発明の薬液含浸シートにおいては、薬液含浸シートの使用目的にもよるが、シート100重量部に対して100〜2000重量部の薬液が含浸されていることが好ましい。本発明が対象とする薬液には化粧用薬液および医用薬液が含まれる。即ち、本発明において薬液含浸シートとは、フェイスマスクのような美容目的の薬液含浸シート、創傷被覆材や薬剤徐放性の貼布材のような医用目的の薬液含浸シートの総称を意味する。   In the chemical liquid impregnated sheet of the present invention, although depending on the purpose of use of the chemical liquid impregnated sheet, it is preferable that 100 to 2000 parts by weight of the chemical liquid is impregnated with respect to 100 parts by weight of the sheet. The chemicals targeted by the present invention include cosmetic chemicals and medical chemicals. That is, in the present invention, the chemical liquid-impregnated sheet means a generic name of a cosmetic liquid-impregnated sheet for cosmetic purposes such as a face mask, and a medical liquid-impregnated sheet for medical purposes such as a wound dressing or a sustained-release medicine patch.

以下、実施例を挙げて本発明をより詳細に説明する。尚、物性の主な測定値は以下の方法で測定した。
(1)ゼータ電位評価方法
シート表面の表面ゼータ電位はスペクトリス社製のゼータサイザーナノZSTMを用いて測定した。測定条件として、測定セルには平板セルZEN1020、測定溶媒には塩化カリウム0.01mol/L水溶液を1〜1.5ml、トレーサー粒子には負電荷に帯電したラテックス粒子または正電荷に帯電した酸化チタン粒子を用いた。測定は25℃で行った。
Hereinafter, the present invention will be described in more detail with reference to examples. The main measured values of physical properties were measured by the following methods.
(1) Zeta potential evaluation method The surface zeta potential of the sheet surface was measured using Zeta Sizer Nano ZS TM manufactured by Spectris. As measurement conditions, flat cell ZEN1020 is used as a measurement cell, 1 to 1.5 ml of potassium chloride 0.01 mol / L aqueous solution is used as a measurement solvent, latex particles charged negatively or titanium oxide charged positively is used as tracer particles. Particles were used. The measurement was performed at 25 ° C.

(2)平均繊維径
シート表面に関して、無作為に3箇所、走査型電子顕微鏡(SEM)による観察を1000倍から10000倍相当の倍率で行う。得られたSEM画像に対し、画面に対し水平方向と垂直方向にラインを引き、ラインに交差する繊維の繊維径を拡大画像から実測し、交差する繊維の個数と各繊維の繊維径を数える。こうして一つの画像につき縦横2系列の測定結果を用いて数平均繊維径を算出する。さらに抽出した他の2つのSEM画像についても同じように数平均繊維径を算出し、合計3画像分の結果を平均化し、対象とする試料の平均繊維径とする。
(2) Average fiber diameter With respect to the sheet surface, observation at 3 locations at random is carried out with a scanning electron microscope (SEM) at a magnification equivalent to 1000 to 10,000 times. With respect to the obtained SEM image, a line is drawn in the horizontal direction and the vertical direction with respect to the screen, and the fiber diameter of the fiber intersecting the line is measured from the enlarged image, and the number of intersecting fibers and the fiber diameter of each fiber are counted. In this way, the number average fiber diameter is calculated using two series of measurement results for one image. Further, the number average fiber diameter is calculated in the same manner for the other two extracted SEM images, and the results for a total of three images are averaged to obtain the average fiber diameter of the target sample.

(3)目付
目付の評価は、JIS P 8124に準じて、算出した。
(4)厚み測定方法
室温20℃、湿度65%RHの雰囲気下で、調湿した不織布構造体をハイブリッジ製作所製のオートマティックマイクロメーターにて測定した。
(3) Weight per unit area The weight per unit area was calculated according to JIS P 8124.
(4) Thickness measuring method The humidity-controlled nonwoven fabric structure was measured with an automatic micrometer manufactured by Hibridge Corporation under an atmosphere of room temperature of 20 ° C. and humidity of 65% RH.

(5)フェイスマスク着用感評価方法
一定の顔型に打ち抜いたシート100重量部に対して、保湿液(カネボウコスミリオン(株)製 うるり)を1000重量部含浸させたフェイスマスクを作製し、40歳代の女性パネラー10人に着用させ、装着時の密着感、取り扱い性、さらには着用後の3時間経過後の保湿性を官能評価した。尚、それぞれの評価は5点満点で評価し、10名の平均値(小数点以下は四捨五入)を算出した。
5点:密着感、取扱い性、保湿性が抜群に優れる。
4点:密着感、取扱い性、保湿性が良好である。
3点:密着感、取扱い性、保湿性に問題はない。
2点:密着感、取扱い性、保湿性がやや劣る。
1点:密着感、取扱い性、保湿性が悪い。
(5) Face mask wearing feeling evaluation method A face mask impregnated with 1000 parts by weight of a moisturizing liquid (Kanebo Cosmillion Co., Ltd. Ururi) is prepared for 100 parts by weight of a sheet punched into a certain face shape. Ten female panelists in their 40s were allowed to wear, and sensory evaluation was performed for the feeling of closeness and handling at the time of wearing, as well as the moisture retention after 3 hours after wearing. In addition, each evaluation was evaluated on a 5-point scale, and the average value of 10 people (rounded off after the decimal point) was calculated.
5 points: Excellent adhesion, handling and moisture retention.
4 points: Good adhesion, handleability and moisture retention.
3 points: There is no problem in adhesion, handleability, and moisture retention.
2 points: Slightly inferior in adhesion, handling and moisture retention.
1 point: Adhesion feeling, handleability and moisture retention are poor.

(実施例1)
4級アンモニウム塩を含む水溶性ポリマーであるポリジアリルジメチルアンモニウムクロリド(PDADMAC、ニットーボー・メディカル社製、PAS−H−10L、平均分子量200,000)の0.5wt%水溶液を調整し、キュプラレーヨン不織布(旭化成せんい製、商品名:ベンリーゼTM SE603、目付60g/m2、膜厚400μm、密度0.15g/cm3、平均繊維径13μm)を30cm角サイズにカットしたものをステンレスパッド中にて20分浸漬した。次いで純水にて1時間洗浄した後、130℃条件のドラムドライヤー装置で乾燥を行った。乾燥後の重量を秤量したところ、PDADMACの吸着による0.9wt%の重量増が認められた。
Example 1
Prepare a 0.5 wt% aqueous solution of polydiallyldimethylammonium chloride (PDADMAC, manufactured by Nitto Bo Medical, PAS-H-10L, average molecular weight 200,000), which is a water-soluble polymer containing a quaternary ammonium salt, and prepare a cupra rayon nonwoven fabric. (Made by Asahi Kasei Fibers, trade name: Benrize SE603, basis weight 60 g / m 2 , film thickness 400 μm, density 0.15 g / cm 3 , average fiber diameter 13 μm) cut into 30 cm square size in a stainless steel pad 20 Dipped for a minute. Next, after washing with pure water for 1 hour, drying was performed with a drum dryer apparatus at 130 ° C. When the weight after drying was weighed, a 0.9 wt% weight increase due to the adsorption of PDADMAC was observed.

得られた不織布シートの表面ゼータ電位を測定したところ、+41mVであった。
このシートを一定の顔型に打ち抜き、シート100重量部に対して、保湿液(カネボウコスミリオン(株)製 うるり)を1000重量部相当を含浸させた物を用いて、パネラーによる官能評価に供したところ、装着時の密着感、取り扱い性、および着用後の保湿性は、表1に示す結果になった。密着感が大きく改善し、着用後の保湿性も継続的に保たれる良好なフェイスマスクであった。
It was +41 mV when the surface zeta potential of the obtained nonwoven fabric sheet was measured.
This sheet was punched into a certain face shape, and a panel was used for sensory evaluation using 100 parts by weight of the sheet impregnated with 1000 parts by weight of moisturizing liquid (Kanebo Cosmilion Co., Ltd. Ururi). When provided, the feeling of adhesion at the time of wearing, handleability, and moisture retention after wearing were the results shown in Table 1. It was a good face mask that greatly improved the feeling of adhesion and maintained the moisture retention after wearing.

(実施例2)
4級アンモニウム塩を含む水溶性ポリマーであるポリジアリルジメチルアンモニウムクロリド(PDADMAC、ニットーボー・メディカル社製、PAS−H−10L、平均分子量200,000)の3.0wt%水溶液を調整した後は、実施例1と同様の操作をおこなった。PDADMACの吸着による2.3wt%の重量増が認められた。
得られた不織布シートの表面ゼータ電位を測定したところ+58mVであり、これを官能評価に供したところ、装着時の密着感、取り扱い性および着用後の保湿性は、表1に示す結果になった。密着感、着用後の保湿性が継続的に保たれる良好なフェイスマスクであった。
(Example 2)
After preparing a 3.0 wt% aqueous solution of polydiallyldimethylammonium chloride (PDADMAC, manufactured by Nittobo Medical, PAS-H-10L, average molecular weight 200,000), which is a water-soluble polymer containing a quaternary ammonium salt, The same operation as in Example 1 was performed. A weight increase of 2.3 wt% due to the adsorption of PDADMAC was observed.
When the surface zeta potential of the obtained nonwoven fabric sheet was measured, it was +58 mV, and when this was subjected to sensory evaluation, the adhesion feeling at the time of wearing, the handleability, and the moisture retention after wearing were the results shown in Table 1. . It was a good face mask in which the feeling of adhesion and moisture retention after wearing were continuously maintained.

(比較例1)
キュプラレーヨン不織布(旭化成せんい製、商品名:ベンリーゼTM SE603、目付60g/m2、膜厚400μm、密度0.15g/cm3、平均繊維径13μm)を単独で、表面ゼータ電位を測定したところ、−30mVであった。
このシートを一定の顔型に打ち抜き、実施例1と同様にパネラーによる官能評価に供したところ、装着時の密着感、取り扱い性、さらには着用後の保湿性は、表1に示す結果にになった。密着感が不足し、また保湿性が保持されていない、すなわち薬効性分が皮膚へ浸透し難いフェイスマスクであることが判明した。
(Comparative Example 1)
When the surface zeta potential was measured independently for a cupra rayon nonwoven fabric (Asahi Kasei Fibers, trade name: Benrize SE603, basis weight 60 g / m 2 , film thickness 400 μm, density 0.15 g / cm 3 , average fiber diameter 13 μm), It was −30 mV.
When this sheet was punched into a certain face shape and subjected to sensory evaluation by a paneler in the same manner as in Example 1, the adhesion feeling at the time of wearing, handleability, and moisture retention after wearing were as shown in Table 1. became. It has been found that the face mask has insufficient adhesion and does not retain moisture retention, i.e., it is difficult for medicinal components to penetrate into the skin.

Figure 2014201588
Figure 2014201588

本発明により、装着時の密着性が格段に高く、且つ化粧料の保液性と皮膚への薬液浸透に優れた薬液含浸シート及びそれを用いたフェイスマスクを提供することが可能となる。   According to the present invention, it is possible to provide a chemical liquid-impregnated sheet that has remarkably high adhesion at the time of wearing, and excellent in liquid retention of cosmetics and chemical liquid permeation into the skin, and a face mask using the same.

Claims (5)

少なくとも片面の表面ゼータ電位の絶対値が35mV以上250mV以下の範囲にあることを特徴とする薬液含浸シート。   A chemical solution-impregnated sheet, wherein the absolute value of the surface zeta potential on at least one side is in the range of 35 mV to 250 mV. 繊維からなる構造体から構成され、少なくとも表面ゼータ電位が前記範囲にある面の平均繊維径が0.01μm以上50μm以下であり、かつ空隙率が50%から90%であることを特徴とする請求項1に記載の薬液含浸シート。   It is composed of a structure composed of fibers, and at least the surface zeta potential in the above range has an average fiber diameter of 0.01 μm or more and 50 μm or less, and a porosity of 50% to 90%. Item 2. A chemical-impregnated sheet according to Item 1. 前記構造体がセルロース系繊維の不織布を含むことを特徴とする請求項2に記載の薬液含浸シート。   The chemical structure impregnated sheet according to claim 2, wherein the structure includes a nonwoven fabric of cellulosic fibers. シート100重量部に対して100〜2000重量部の薬液が含浸されていることを特徴とする請求項1〜3のいずれか一項に記載の薬液含浸シート。   The chemical liquid impregnated sheet according to any one of claims 1 to 3, wherein 100 to 2000 parts by weight of the chemical liquid is impregnated with respect to 100 parts by weight of the sheet. 請求項1〜4のいずれか一項に記載の薬液含浸シートからなることを特徴とするフェイスマスク。   A face mask comprising the chemical liquid impregnated sheet according to any one of claims 1 to 4.
JP2013082174A 2013-04-10 2013-04-10 Medicine-impregnated sheet with controlled zeta potential and face mask Pending JP2014201588A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013082174A JP2014201588A (en) 2013-04-10 2013-04-10 Medicine-impregnated sheet with controlled zeta potential and face mask

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013082174A JP2014201588A (en) 2013-04-10 2013-04-10 Medicine-impregnated sheet with controlled zeta potential and face mask

Publications (1)

Publication Number Publication Date
JP2014201588A true JP2014201588A (en) 2014-10-27

Family

ID=52352347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013082174A Pending JP2014201588A (en) 2013-04-10 2013-04-10 Medicine-impregnated sheet with controlled zeta potential and face mask

Country Status (1)

Country Link
JP (1) JP2014201588A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02127595A (en) * 1988-11-04 1990-05-16 Scott Paper Co Chemically treated paper product-towel and tissue
JP2001170104A (en) * 1999-12-22 2001-06-26 Asahi Kasei Corp Wetting base material and method for using the same
JP2005330639A (en) * 2004-04-21 2005-12-02 Toray Ind Inc Method for producing nano fiber structural material
JP2006273790A (en) * 2005-03-30 2006-10-12 Pias Arise Kk Cationic polymer micell medicinal carrier, dispersant containing the medicinal carrier, and skin care preparation and cosmetic blended with the medicinal carrier
WO2011004834A1 (en) * 2009-07-07 2011-01-13 クラレクラフレックス株式会社 Laminated sheet, and process for production thereof
JP2012153666A (en) * 2011-01-27 2012-08-16 Kao Corp Sheet-like cosmetic
JP2012197250A (en) * 2011-03-22 2012-10-18 Lion Corp Sheet cosmetic product
JP2014205924A (en) * 2013-04-10 2014-10-30 旭化成せんい株式会社 Sheet impregnated with chemical

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02127595A (en) * 1988-11-04 1990-05-16 Scott Paper Co Chemically treated paper product-towel and tissue
JP2001170104A (en) * 1999-12-22 2001-06-26 Asahi Kasei Corp Wetting base material and method for using the same
JP2005330639A (en) * 2004-04-21 2005-12-02 Toray Ind Inc Method for producing nano fiber structural material
JP2006273790A (en) * 2005-03-30 2006-10-12 Pias Arise Kk Cationic polymer micell medicinal carrier, dispersant containing the medicinal carrier, and skin care preparation and cosmetic blended with the medicinal carrier
WO2011004834A1 (en) * 2009-07-07 2011-01-13 クラレクラフレックス株式会社 Laminated sheet, and process for production thereof
JP2012153666A (en) * 2011-01-27 2012-08-16 Kao Corp Sheet-like cosmetic
JP2012197250A (en) * 2011-03-22 2012-10-18 Lion Corp Sheet cosmetic product
JP2014205924A (en) * 2013-04-10 2014-10-30 旭化成せんい株式会社 Sheet impregnated with chemical

Similar Documents

Publication Publication Date Title
EP2453047B1 (en) Laminated sheet, and process for production thereof
EP2860307B1 (en) Liquid-retaining sheet and face mask
EP2589692B1 (en) Nanofibre laminate sheet
US10603230B2 (en) Low friction core-shell nanofibrous membranes for delivery of active ingredients to the wet skin
US20110256397A1 (en) Method for attaching nanofiber sheet
JP6734072B2 (en) Cellulose fiber non-woven fabric for face mask
JP6385191B2 (en) Chemical solution impregnation sheet and face mask using the same
KR20170077658A (en) soft nano mask pack using complex nano fiber sheet and the method for preparing thereof
RU2579263C2 (en) Textile antimicrobial material with multicomponent nano-membranes and preparation method thereof
JP2019077660A (en) Production method of cosmetic sheet
KR20170050111A (en) Hydrogel pack for moisturizing having enhanced moisture content containing carbon fiber or carbon nano tube
JP2017114030A (en) Laminate sheet having water-soluble nanofiber layer
JP5451837B2 (en) Fiber cross-linked body and method for producing fiber cross-linked body
JP2014201588A (en) Medicine-impregnated sheet with controlled zeta potential and face mask
KR101614324B1 (en) Biocompatible nanofiber web and manufacturing method thereof
KR102366887B1 (en) Nanofiber sheet, its use method, and its manufacturing method
JP2012012710A (en) Nanofiber sheet
WO2021251213A1 (en) Non-woven fabric, liquid-impregnated sheet, and wiping sheet
JP2009091682A (en) Fiber crosslinked body and method for producing fiber crosslinked body
JP2013163871A (en) Nonwoven fiber sheet and wiper comprising the same
JPWO2016204280A1 (en) Beauty face mask sheet
JP6795317B2 (en) Method for manufacturing a laminated sheet having a gel precursor layer
KR102274598B1 (en) Nanofiber Mask sheet composed of soluble and insoluble polymers
JP6824023B2 (en) Nanofibers, nanofiber manufacturing methods and masks
WO2021192985A1 (en) Nonwoven fabric, method for producing same, sheet impregnated with liquid, and wiping sheet

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160215

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20160404

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20161222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170704